Named Patient Service

Named patient programs (NPP) provide controlled, pre-approval access to medicines in response to requests by physicians on behalf of specific, or “named”, patients before those medicines are licensed in the patient’s home country.

Through these programs, patients are able to access medicines in late-stage clinical trials or approved in other countries for a genuine, unmet medical need, before those medicines have been licensed in the patient’s home country.